TRENDSPOTTER: The Festo Decision and its Effects on Genomics Patents | GenomeWeb

GENOMICS is a new field in which patents have only recently been issued. The scope of protection afforded these patents had been interpreted and governed by a recognized body of law and rules. However, as a result of a recent decision, Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki , those rules have changed. These changes affect the enforceability of issued patents, license agreements, pending patent applications, and potential patent applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.